baber/WOPTO huggingface dataset:
Patent NZ-566706-A (NZ)
Title: A phenolic foam for insulation applications in construction materials
Inventor: COPPOCK VINCENT
IPC: C08J9/00
Filed: 2006-09-08
Abstract: Disclosed is a phenolic foam made by foaming and curing a foamable phenolic resin composition that comprises a phenolic resin, a blowing agent, an acid catalyst and an inorganic filler. The blowing agent comprises a blend of chlorinated aliphatic hydrocarbon containing 2 to 5 carbon atoms and an aliphatic hydrocarbon containing from 3 to 6 carbon atoms mixed in a ratio of 60/40 to 95/5 parts by weight. The inorganic filler is at least one selected from a metal hydroxide, a metal oxide, a metal carbonate and a metal powder. The phenolic foam has a pH of 5 or more and a water uptake less than 1 kg/m2. A phenolic foam with a higher pH value compared with conventional phenolic foam reduces corrosion risk when in contact with metallic materials. The phenolic foam maintains excellent long-term stable thermal insulation performance, low water uptake and fire resistance performance and by using the said blowing agent, does not harm the environment as an ozone or global warming depleting material.
Patent NZ-570105-A (NZ)
Title: Animal collar adaptable for convertion between a fixed collar and a choke collar with a minimum circumference
Inventor: GARCIA MICHAEL
IPC: A01K15/00
Filed: 2006-12-28
Abstract: An animal collar is disclosed. The collar enables the ring for connecting a leash to be attached to the collar itself when not in use. The collar has an elongate flexible member (1) which first and second ends. The first end is provided with a runner line (3) with a lead connector (5). The second end has a running ring (4) such that the runner line (3) can pass through to form a closed loop of variable circumference. Attachment means (8) is mounted on the flexible member (1) near the running ring (4) so that when the lead connector (5) is not attached to a lead, the runner line (3) and the lead connector (5) can be held substantially flush with the flexible member (1) by attaching the attachment means (8) to the lead connector (5) or the runner line (3).
Patent NZ-571035-A (NZ)
Title: Optical characterising system which senses selected light from a radiation source
Inventor: KALITSIS JOHN
IPC: G01N21/35
Filed: 2007-02-21
Abstract: A field-use optical grain characterising system (101) is disclosed. The system (101) includes a generally rectangular prismatic composite body (102) that defines a component cavity (103). A substantially vertical elongate channel extends within cavity (103) for housing a grain sample. An electromagnetic radiation source (105) is disposed within cavity (103) for directing light into channel. An optical detection system is disposed within cavity (103) for sensing selected light emerging from channel and for providing a sensor signal. A processor, which is included within the optical detection system, is also disposed within cavity (103) and is responsive to the sensor signal for providing data indicative of a characteristic parameter of the grain sample. A display device (108), such as touch screen LCD display, is connected with body (102) for selectively presenting the data.
Patent NZ-582971-A (NZ)
Title: Method for surface pasteurization and sterilization of pieces of food
Inventor: PERREN RAINER
IPC: A23L7/152
Filed: 2008-04-12
Abstract: Disclosed is a method for the surface pasteurization or surface sterilization of pieces of food products, wherein the food products are employed pre-warmed, and the product temperature lies below the evaporation temperature of the pasteurization or sterilization systems, the pre- warming temperature of the food products is selected to be lower than the saturation temperature, treatment is performed in a moist atmosphere free of air, wherein pasteurization is performed at temperatures between 55 and 99°C at low pasteurization pressure, or sterilization at temperatures between 100°C and 140°C at a higher sterilization pressure, heat treatment is performed in the course of 1 to 30 min, and the condensation water is removed from the surface of the food products by means of subsequent vacuum drying under further reduced pressure.
Patent NZ-583656-A (NZ)
Title: A hinge arrangement for a cigarette display cabinet which allows a cabinet door to automatically swing shut
Inventor: DEMOURTZIDIS GEORGE
IPC: E05D3/02
Filed: 2010-03-02
Abstract: A hinge arrangement mountable to a cabinet door of a cigarette display cabinet is disclosed. The hinge arrangement includes; a door mounting plate (16), a cabinet mounting plate (14), and a support rod (19). The mounting plates have areas enclosing ends of the support rod (15) (17) to allow support and pivoting. The edges of the plates are inclined (18) (19) (23) (25). The door plate rotates to an upwards position when the door is opened. When the open door is released, gravity allows the upward plate (16) to rotate downwards and the door to swing shut.
Patent NZ-587553-A (NZ)
Title: A new class of chloroflexi-iike thermophilic cellulose degrading bacteria
Inventor: STOTT MATTHEW BRYAN
IPC: C02F3/34
Filed: 2009-03-11
Abstract: Disclosed is a new class of Chloroflexi-like bacteria. The bacteria are thermophilic cellulose degrading bacteria. Compositions and methods for degrading cellulose using the Chloroflexi-like bacteria are also provided.
Patent NZ-587951-A (NZ)
Title: Phenol-containing azole compositions for the protection of industrial materials
Inventor: KOOP BERND
IPC: C07C39/04
Filed: 2010-09-13
Abstract: Disclosed is a composition comprising at least one azole and at least one phenol of formula (I). Examples of azoles are azaconazole, bitertanol, bromuconazole, cyproconazole, dic1obutrazol, difenoconazole, diniconazole, epoxyconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furconazole, hexaconazole, imibenconazole, ipconazole, myc1obutanil, metconazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole and uniconazole. Example of phenol is 6,6' -di-tert-butyl-2,2' -methylenedi-p-cresol. Also disclosed is the use of the composition for protecting industrial materials, industrial materials comprising the composition and the process for protecting an industrial material with the composition.
Patent NZ-590083-A (NZ)
Title: A nail loader with guides for short nails
Inventor: HERELIER PATRICK
IPC: B25C1/00
Filed: 2009-06-18
Abstract: 590083 A loader for a nails strip, comprising an end 7 for introducing the nails strip 24, an outlet end 8 for the strip 24 arranged so as to be mounted on a nose of a fixing device, guiding means 10 for guiding nails 25 from the introduced end 7 to the outlet end 8 and means for pushing the strip 24 to the outlet end 8, the guiding means 10 comprising abutting means for nails 25 extending up to the outlet end 8. The guiding means 10 is provided with a window for rocking short nails. The window has a rear edge 14 and a front edge 15 forming an abutment for the short nails.
Patent NZ-593102-A (NZ)
Title: Dihydroetorphines and their preparation
Inventor: WHITELOCK STEVE
IPC: A61K31/4353
Filed: 2009-12-04
Abstract: Abstract - 593102 Disclosed is a process for the preparation of a compound of formula (VI) such as S-dihydroetorphine, or a salt thereof, wherein: R1 and R2 are independently C1-8straight-chained alkyl and * represents a (S) stereocentre) comprising reacting a compound of formula (IV) with a compound of formula R2M(X)p, wherein R2 is C1-8 straight-chained alkyl, M is a metal, X is halide and p is 1 or 0 (and preferably where R2M(X)p is MeMgBr) to produce a compound of formula (V) and hydrolysing said compound of formula (V). Also disclosed is a process of preparing a compound of (IV) (such as 20-ethyldihydrothevinone) which includes reacting thebaine with a compound such as 1-hexen-3-one to give 20-?-ethylthevinone, followed by a hydrogenation reaction. Also disclosed is a compound of formula (V) which is (S)-19-propyldihydrothevinol.
Patent NZ-598654-A (NZ)
Title: Immunogenic compositions including tlr activity modulators
Inventor: SINGH MANMOHAN
IPC: A61K31/04
Filed: 2010-09-01
Abstract: 598654 Disclosed herein are a class of compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 7 (TLR7). In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine. In one embodiment the immunogenic composition comprises a TLR7 agonist of Formula (I) as defined in the specification, or a pharmaceutically acceptable salt, an antigen, and an aluminium-containing adjuvant selected from aluminium hydroxide, alumina oxyhydroxide and aluminium hydroxyphosphate. In one embodiment, the TLR7 agonist is 3-((4-{ 2-(5-amino-8-methylbenzo[f][1,7]naphthyridin-2-yl)ethyl)-3-methylphenoxy)methyl)phenyl-phosphonic acid
Patent NZ-610893-A (NZ)
Title: Fermentive production of four carbon alcohols
Inventor: DONALDSON GAIL K
IPC: C12P7/16
Filed: 2006-10-25
Abstract: A method for the recovery of isobutanol comprising culturing a recombinant microbial host cell in a fermentation medium under conditions whereby isobutanol is produced, and recovering the isobutanol; wherein said fermentation medium comprises a fermentable carbon substrate; and wherein said recombinant microbial host cell comprises a heterologous DNA molecule encoding polypeptides that catalyze substrate to product conversions for: i) pyruvate to acetolactate (pathway step a) ii) acetolactate to 2,3-dihydroxyisovalerate (pathway step b) iii) 2,3-dihydroxyisovalerate to α-ketoisovalerate (pathway step c) iv) α-ketoisovalerate to isobutyraldehyde, (pathway step d) and v) isobutyraldehyde to isobutanol, (pathway step e) wherein the DNA molecule is heterologous to said microbial host cell.
Patent NZ-614634-A (NZ)
Title: Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
Inventor: KWIATKOWSKI STEFAN
IPC: C12N1/14
Filed: 2011-09-16
Abstract: Discloses a composition comprising soluble selenoglycoproteins, wherein the soluble selenoglycoproteins contain a single or two or more pH dependent fractions of the selenoglycoproteins, wherein the soluble selenoglycoproteins are obtained via acid extraction of the soluble selenoglycoproteins from selenium enriched yeast. Also discloses a method for the preparation of soluble selenoglycoproteins from selenium enriched yeast.
Patent NZ-616696-A (NZ)
Title: Yeast-brachyury immunotherapeutic compositions
Inventor: APELIAN DAVID
IPC: A61P35/00
Filed: 2012-03-19
Abstract: Disclosed are immunotherapeutic compositions comprising: a) a yeast vehicle; and b) a cancer antigen comprising at least one Brachyury antigen, wherein the Brachyury antigen comprises SEQ ID NO:6, positions 2-435 of SEQ ID NO:6, SEQ ID NO:18, positions 2-435 of SEQ ID NO:18, or an amino acid sequence that is at least 95% identical to SEQ ID NO:18 and comprises a substitution of a leucine at position 254 with a valine, wherein the sequences are as defined in the complete specification. Also disclosed is use the composition in treating, delaying onset of, or preventing cancer.
Patent NZ-617563-A (NZ)
Title: Dispersants having biobased compounds
Inventor: BASEETH SHIREEN S
IPC: C09D7/45
Filed: 2012-05-10
Abstract: Disclosed herein are compositions in the form of a thermodynamically stable, nano-dispersion, comprising: a lecithin; an organic acid; a salt of the organic acid, an ester of the organic acid, or a combination thereof; and water. The disclosed compositions may also include one or more co-surfactants such as anionic surfactants and/or non-ionic surfactants. Also disclosed are products made with the composition and processes for making such compositions.
Patent NZ-622005-A (NZ)
Title: Antisense compounds targeted to connexins and methods of use thereof
Inventor: WILDA LAUX
IPC: C12N15/11
Filed: 2004-12-03
Abstract: Disclosed is the use of a connexin 43 antisense compound for the manufacture of a medicament for treating tissue damage in an anterior segment or posterior segment of the eye in a subject, wherein said medicament is formulated to provide a therapeutically effective amount of an anti-connexin 43 antisense compound to the anterior segment or posterior segment of the eye or in cells associated with the cornea, conjunctiva, sclera or posterior segment of the eye of said subject. Further disclosed is the use of a connexin 43 antisense compound for the manufacture of a medicament for tissue engineering of the eye of a subject by modulating the proliferation, migration, or differentiation of cells in the cornea, conjunctiva, sclera or posterior segment of the eye or on cells associated with the eye of the subject, wherein said medicament is formulated to provide a therapeutically effective amount of an anti-connexin 43 antisense compound to an anterior segment or posterior segment of the eye of a subject or in cells associated with the anterior segment or posterior segment of the eye. Further disclosed is the use of a connexin 43 antisense compound for the manufacture of a medicament for promoting the accumulation of epithelial cells in an anterior segment or posterior segment of the eye or in a tissue associated with the anterior segment or posterior segment of the eye of a subject, wherein said medicament is formulated to provide a therapeutically effective amount of an anti-connexin 43 antisense compound to the cornea, conjunctiva, sclera or posterior segment of the eye or in a tissue associated with the cornea, conjunctiva, sclera or posterior segment of the eye of said subject. Further disclosed is the use of a connexin 43 antisense compound for the manufacture of a medicament for inhibiting hypercellularity in an anterior segment or posterior segment of the eye or in a tissue associated with the anterior segment or posterior segment of the eye of a subject, wherein said medicament is formulated to provide a therapeutically effective amount of an anti-connexin 43 antisense compound to the eye of a subject. Further disclosed is the use of a connexin 43-downregulating amount of a connexin 43 antisense compound, in the manufacture of a medicament for treating a subject for posterior segment disorders of the eye.
Patent NZ-625468-A (NZ)
Title: Methods and materials for assessing loss of heterozygosity
Inventor: ABKEVICH VICTOR
IPC: C12Q1/68
Filed: 2012-12-21
Abstract: A method for assessing loss of heterozygosity (LOH) in a cancer cell or genomic DNA thereof, comprises (a) detecting, in a cancer cell or genomic DNA derived therefrom, LOH regions in at least one pair of human chromosomes of the cancer cell with at least one pair of human chromosomes not being a human X or Y sex chromosome pair; and (b) determining the total number of LOH regions, in the at least one pair of human chromosomes, that are longer than a first length but shorter than the length of the whole chromosome containing the LOH region, with the first length being about 1.5 or more megabases. A method of predicting the status of BRCA1, BRCA2 or HDR genes in a cancer cell, comprises determining, in the cancer cell, the total number of LOH regions in at least one pair of human chromosomes of the cancer cell that are longer than a first length but shorter than the length of the whole chromosome containing the LOH region, with at least one pair of human chromosomes not being a human X or Y sex chromosome pair with the first length being about 1.5 or more megabases; and correlating the total number that is greater than a reference number with an increased likelihood of a deficiency in the HDR, BRCA1 or BRCA2 gene.
Patent NZ-626081-A (NZ)
Title: Fibre optic splice closure
Inventor: GAUCI MICHAEL
IPC: G02B6/46
Filed: 2012-11-23
Abstract: Disclosed herein is a fibre optic splice closure comprising a splice holder having first and second opposing sides; and at least one optical fibre entry point and at least one optical fibre exit point. The closure defines a plurality of optical fibre pathways within the closure, whereby a first optical fibre can be selectively directed from the at least one entry point to either side of the splice holder and whereby a second optical fibre spliced to the first optical fibre in the splice holder can be selectively directed from the opposing side of the splice holder to the at least one exit point. The closure comprises members about which the first and second optical fibres are windable to follow the plurality of optical fibre pathways within the closure. The members comprise reels located adjacent the splice holder, each reel comprising a central annular body and a plurality of wings extending radially outwardly from the central annular body and adapted to retain the optical fibers. The optical fibres are windable around the reels such that they follow at least part of a figure 8 path and can thereby be selectively directed from the entry point to either side of the splice holder, and from the opposing side of the splice holder to the exit point. The optical fibres are windable around and in contact with the entire annular peripheries of the central annular bodies of the reels.
Patent NZ-701797-A (NZ)
Title: Density phase separation device
Inventor: BARTFELD BENJAMIN
IPC: G01N1/10
Filed: 2010-05-14
Abstract: A mechanical separator (40) for separating a fluid sample into first and second phases within a collection container (82) is disclosed. The mechanical separator (40) has a separator body with a through-hole (46) adapted for allowing fluid to pass through. The separator body includes a float (42), having a first density, and a ballast (44), having a second density greater than the first density. The body also includes a seal between the separator (40) and the container (82). In use the separator changes position in a centrifuge from a position in which fluid can flow (F) through the hole to a closed position.
Patent NZ-701862-A (NZ)
Title: Wheelchair
Inventor: TUCKOWSKI THOMAS
IPC: A61G5/10
Filed: 2011-06-24
Abstract: The present disclosure relates generally to conveyances and, more particularly, to wheelchairs. In one embodiment, a wheelchair includes a seat assembly coupled to a chassis. The chassis includes a frame having a rear wheel support member, one or more front wheel support members extending in a forward direction from the rear wheel support member, and a seat support member. The rear wheel support member comprises a central portion and left and right portions extending downward from the central portion. The wheelchair also includes one or more drive wheels for propulsion of the wheelchair, a set of front wheels for supporting the wheelchair, and a shrouding system for at least partially covering the frame and other components of the wheelchair.
Patent NZ-716707-A (NZ)
Title: Astragalus membranaceus seed extract and use thereof for preparing animal feed and foods
Inventor: ZHOU RAN
IPC: A61P37/00
Filed: 2013-08-15
Abstract: Disclosed is an Astragalus membranaceus seed extract prepared from Astragalus membranaceus seed which is firstly degreased with petroleum ether, extracted with an alkaline liquor and then treated with an acid to give a precipitate, and then freeze-drying the precipitate, wherein the protein content is as high as 87.0%, and the total amount of amino acids is 78.34 %. The extract can be used as feed additives or food additives, and has functions such as improving human or animal immune and lipid metabolisms.
Patent NZ-719619-A (NZ)
Title: Selective capture and presentation of native image portions
Inventor: DAVIES MICHAEL
IPC: H04N21/2343
Filed: 2012-08-06
Abstract: A system and method for selective capture of and presentation of native image portions are provided. In a first embodiment a first image or video is captured at a first resolution, which resolution is greater than high definition and higher than a predetermined broadcast display resolution. A desired portion of the native, first image or video is then displayed at a second, lower resolution, which resolution is less than and closer to the predetermined broadcast display resolution. Accordingly, a selected portion of the captured image may be displayed at or near the predetermined broadcast display resolution. In other exemplary embodiments, video is captured at a first frame rate that is higher than a predetermined broadcast frame rate, and an extraction window extracts frames from a portion of the native, first video to provide improved broadcast quality of the portion(s) selected by the extraction window.
Patent NZ-724542-A (NZ)
Title: Molten metal stirring device and molten metal transfer device
Inventor: TAKAHASHI KENZO
IPC: F27D27/00
Filed: 2015-03-26
Abstract: [Problem] To provide an efficient device for stirring molten metal and an efficient device for transferring molten metal [Solution] The present invention is constituted to stir or transfer molten metal using a driving force combined from a first electromagnetic force and a second electromagnetic force. The first electromagnetic force is derived from an eddy current generated in the molten steel using magnetic lines of flux from a rotating permanent magnet, and the second electromagnetic force deriving from Fleming’s law from the intersection of a current flowing between a pair of electrodes provided in advance and the magnetic lines of flux.
Patent NZ-731389-A (NZ)
Title: Benzylpropargylether as nitrification inhibitors
Inventor: PASDA GREGOR
IPC: C05G3/60
Filed: 2015-11-13
Abstract: The present invention relates to the use of compounds of formula (I) for reducing nitrification and to compositions comprising the compounds of formula (I) and to agricultural mixtures comprising at least one compound of formula (I) and at least one fertilizer. Furthermore, the present invention relates to a method for reducing nitrification comprising treating a plant growing on soil or soil substituents and/or the locus or soil or soil substituents where the plant is growing or is intended to grow with a compound of formula (I) or a composition comprising a compound of formula (I)
Patent NZ-734875-A (NZ)
Title: A bracket
Inventor: PATEL ANIL RAMAN
IPC: A61G5/10
Filed: 2016-02-19
Abstract: There is a need for postural supports which can be easily moved between a variety of different positions and be able to adopt various angled and/or tilted positions to suit the needs of physically disabled people that tend to slouch forward and/or sideways. Provided is a postural support bracket for a seat comprising a first positioning member and a second position member. Each positioning member comprising a first portion, a second portion, and a middle portion extending at an angle between the first and second portions. The first portion is rotatably attachable to the seat and the second portion is rotatably attached to a support brace. The support brace comprises a body further comprising at least one tilt adjustment slot. The second portion of at least one positioning member is slidingly engaged with the at least one tilt adjustment slot by a respective attachment system to vary an angle of tilt of the support brace. The support brace is formed in two parts. A first part being hingedly attached to a second part and wherein the first positioning member is rotatably attached to the first part and the second positioning member is rotatably attached to the second part to allow the support brace to rotate about the second portion of each positioning member. Each of the attachment systems is adapted to prevent rotation of the second portion of the respective positioning member to lock an angle of tilt of the first and second parts of the support brace. The postural support bracket is adapted to allow the postural support to adopt a variety of different positions, including positions in which the postural support is tilted in order to suit postural support requirements of different people.